Skip to main content
Kent Academic Repository

Aprepitant is a novel, selective activator of the K2P channel TRAAK

McCoull, D., Veale, Emma L., Walsh, Yvonne, Byrom, L., Avkiran, T., Large, J.M., Vaitone, E., Gaffey, F., Jerman, J., Mathie, Alistair, and others. (2021) Aprepitant is a novel, selective activator of the K2P channel TRAAK. Biochemical and Biophysical Research Communications, 588 . pp. 41-46. ISSN 0006-291X. (doi:10.1016/j.bbrc.2021.12.031) (KAR id:92477)

Item Type: Article
DOI/Identification number: 10.1016/j.bbrc.2021.12.031
Subjects: R Medicine > RM Therapeutics. Pharmacology
Institutional Unit: Schools > Medway School of Pharmacy
Former Institutional Unit:
Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User: Alistair Mathie
Date Deposited: 27 Dec 2021 14:12 UTC
Last Modified: 20 May 2025 09:57 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/92477 (The current URI for this page, for reference purposes)

University of Kent Author Information

Veale, Emma L..

Creator's ORCID: https://orcid.org/0000-0002-6778-9929
CReDIT Contributor Roles:

Walsh, Yvonne.

Creator's ORCID:
CReDIT Contributor Roles:

Mathie, Alistair.

Creator's ORCID: https://orcid.org/0000-0001-6094-2890
CReDIT Contributor Roles:
  • Depositors only (login required):

Total unique views of this page since July 2020. For more details click on the image.